Meeder Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-301
| Closed | -$11K | – | 2085 |
|
|
2021
Q3 | $11K | Hold |
301
| – | – | ﹤0.01% | 1631 |
|
|
2021
Q2 | $13K | Sell |
301
-251
| -45% | -$10.8K | ﹤0.01% | 1613 |
|
|
2021
Q1 | $19K | Buy |
+552
| New | +$19K | ﹤0.01% | 1422 |
|
|
2020
Q4 | – | Sell |
-2,238
| Closed | -$54K | – | 2162 |
|
|
2020
Q3 | $54K | Hold |
2,238
| – | – | ﹤0.01% | 944 |
|
|
2020
Q2 | $40K | Hold |
2,238
| – | – | ﹤0.01% | 973 |
|
|
2020
Q1 | $35K | Sell |
2,238
-4,358
| -66% | -$68.2K | ﹤0.01% | 1042 |
|
|
2019
Q4 | $141K | Buy |
6,596
+2,911
| +79% | +$62.2K | 0.01% | 700 |
|
|
2019
Q3 | $68K | Buy |
3,685
+3,536
| +2,373% | +$65.3K | ﹤0.01% | 914 |
|
|
2019
Q2 | $4K | Buy |
149
+14
| +10% | +$376 | ﹤0.01% | 1733 |
|
|
2019
Q1 | $3K | Hold |
135
| – | – | ﹤0.01% | 1508 |
|
|
2018
Q4 | $3K | Buy |
135
+12
| +10% | +$267 | ﹤0.01% | 1523 |
|
|
2018
Q3 | $4K | Buy |
123
+68
| +124% | +$2.21K | ﹤0.01% | 1374 |
|
|
2018
Q2 | $1.55K | Hold |
55
| – | – | ﹤0.01% | 1447 |
|
|
2018
Q1 | $2K | Sell |
55
-54
| -50% | -$1.96K | ﹤0.01% | 1391 |
|
|
2017
Q4 | $5K | Buy |
+109
| New | +$5K | ﹤0.01% | 1322 |
|
|
2017
Q3 | – | Sell |
-137
| Closed | -$4K | – | 1738 |
|
|
2017
Q2 | $4K | Hold |
137
| – | – | ﹤0.01% | 1268 |
|
|
2017
Q1 | $5K | Sell |
137
-142
| -51% | -$5.18K | ﹤0.01% | 1086 |
|
|
2016
Q4 | $7K | Buy |
+279
| New | +$7K | ﹤0.01% | 815 |
|